ARS PHARMACEUTICALS INC. - COMMON STOCK

13,53

31-января-25 12:45:03

15 мин. задержка

Акции

-0,76

-5,32%

Сегодняшний диапазон

13,51 - 14,58

ISIN

N/A

Источник

NASDAQ

ARS Pharmaceuticals Announces FDA Advisory Committee for neffy® for the Treatment of Allergic Reactions (Type 1), Including Anaphylaxis

28 мар 2023 09:39:51 Источник Nasdaq GlobeNewswire
ARS Pharmaceuticals Highlights Progress and Reports Fourth Quarter and Full Year 2022 Financial Results

23 мар 2023 16:01:00 Источник Nasdaq GlobeNewswire
ARS Pharmaceuticals Announces Presentation of Data Supporting neffy (epinephrine nasal spray) and Real-World Burden of Needle Injectors

23 фев 2023 16:01:00 Источник Nasdaq GlobeNewswire
ARS Pharmaceuticals Reacquires European Marketing Rights to neffy® (ARS-1) for the Treatment of Type I Allergic Reactions Including Anaphylaxis

22 фев 2023 16:05:01 Источник Nasdaq GlobeNewswire
ARS Pharmaceuticals to Participate in the SVB Securities Virtual Global Biopharma Conference 2023

09 фев 2023 06:30:00 Источник Nasdaq GlobeNewswire
ARS Pharmaceuticals Announces Presentation of Clinical Data Supporting neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (Type I) including Anaphylaxis

10 ноя 2022 08:00:03 Источник Nasdaq GlobeNewswire
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics

08 ноя 2022 16:02:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
3
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.